Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Taxotere, Cisplatin, and 5-FU in Gastric/GEJ Adenocarcinoma
NCT00763646Phase 2Unknown
- Sponsor
- McGill University
- Start
- Apr 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, esophageal adenocarcinoma (EAC), sponsored by McGill University. Status: unknown.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinomaesophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT00763646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763646.